Partnering with medical technology companies to make a difference.

Who are we?

At KCK Medtech, we believe that innovation can transform health care for doctors, patients and loved ones. And we know that lasting innovation can only be achieved through long term commitment and experienced support. By investing in revolutionary medical device companies, we are committed to improving the standard of care for all.

What makes
KCK unique?

The composition of our team is as unique as our capital – we are all former operators who have spent time in leadership roles at medical technology companies, both Fortune 500 and smaller startups.

Aligned

As an evergreen fund, our capital is flexible and long term oriented without the timeline pressures of traditional funds. We embrace the challenges and opportunities that will lead to long term company value for our portfolio.

Experienced

All team members have extensive “Been There Done That” with expertise in bringing numerous products from inception to reality. Our leadership experience spans large and start-up companies both private and public and across all functional areas.

In It Together

We add value beyond the boardroom, taking active roles in identifying talent, solving challenges and lending expertise, even contributing our own seasoned team when needed.

Our Team

The composition of our team is as unique as our capital – we are all former operators who have spent time in leadership roles at medical technology companies, both Fortune 500 and smaller startups.

Greg

Garfield

Sr. Managing Director

Karen

Long

Sr. Managing Director

John

White

Managing Director

Susan

Stimson

Managing Director

Dan

Harfe

Principal

Viral

Gandhi

Principal

Chase

Garfield

Analyst

Selected Portfolio

Aerin Medical

Aerin Medical is focused on delivering ENT physicians tissue-sparing solutions for the treatment of nasal airway conditions.

Allotex

Allotex has created a novel corneal inlay for patients with presbyopia.

Avvio Medical

Avvio Medical is focused on improving patient outcomes in urinary stone disease with innovative new products and procedures built around its SmartSphere technology platform.

Barologics

Barologics is an early stage neuromodulation company focused on developing a closed loop baroreflex system to treat uncontrolled high blood pressure.

Candesant Biomedical

Candesant Biomedical has developed an innovative treatment that provides a quick, in-office solution for excessive underarm sweating.

Cerapedics

Cerapedics has created i-Factor®, a peptide enhanced bone graft that is supported by Level-1 clinical evidence demonstrating superior performance in spinal fusion.

Earlens

Earlens has created an innovative hearing solution that delivers more complete, rich and natural sound than any other hearing device on the market.

Mainstay Medical

Mainstay Medical is advancing an innovative implantable neurostimulation system, ReActiv8, for people suffering from disabling chronic low back pain.

NeuroPace

NeuroPace’s responsive neuromodulation system provides a window to the brain to stop seizures where they start.

RefleXion

RefleXion Medical’s biology-guided radiotherapy (BgRT) allows clinicians to detect and respond to signals emitted from the cancer itself as a guide for radiation therapy.

Revamp

Revamp is developing technology to relieve congestion in patients with acute decompensated heart failure.

Revelle Aesthetics

Revelle Aesthetics is uniquely dedicated to the development of progressive solutions in medical aesthetics with an initial focus on cellulite.

Sight Sciences

Sight Sciences is commercializing Omni®, a unique, less invasive surgical system for glaucoma patients and TearCare®, an in-office treatment for dry eye sufferers.

Sonex Health

Sonex Health is innovating ultrasound guided orthopedic procedures for extremities.